Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
Neurol Neuroimmunol Neuroinflamm
.
2015 Mar 12;2(2):e84.
doi: 10.1212/NXI.0000000000000084.
eCollection 2015 Apr.
Author
Martin S Weber
1
Affiliation
1
Institute of Neuropathology and Department of Neurology, University Medical Centre, Göttingen, Germany.
PMID:
25798446
PMCID:
PMC4360792
DOI:
10.1212/NXI.0000000000000084
No abstract available